The high-sensitivity C-reactive protein level one month after bare-metal coronary stenting may predict late adverse events

Revista Espanola de Cardiologia

Volumn 61, Issue 3, 2008, Pages 313-316

  Fournier, Juan Antonio ^a,b   Delgado Pecellín, Carmen ^a   Cayuela, Aurelio ^a   Cabezón, Soledad ^a   Mendoza, María Dolores ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Espinosa y Carcel 57 9 B   (Spain)

Author keywords

C reactive protein; Coronary angioplasty; Coronary stent

Indexed keywords

C REACTIVE PROTEIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DISEASE FREE SURVIVAL; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; STABLE ANGINA PECTORIS; SURVIVAL RATE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PROSTHESIS; STENT; TIME;

C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SENSITIVITY AND SPECIFICITY; STENTS; TIME FACTORS;

EID: 44449144011     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13116660     Document Type: Article

References (12)

1. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-97.
2. Azar RR, McKay RG, Kiernan FJ, Seecharran B, Feng YJ, Fram DB, et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol. 1997;80:1476-8.
3. Ramadan MM, Kodama M, Mitsuma W, Ito M, Kashimura T, Ikrar T, et al. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive Protein in the coronary circulation of subjects with coronary artery disease. Am J Cardiol. 2006;98:915-7.
4. Rahel BM, Visseren FLJ, Suttorp MJ, Plokker THW, Kelder JC, de Jongh BM, et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res. 2003;60:136-40.
5. Segev A, Kassam S, Buller CE, Lau HK, Sparkes JD, Connelly PW, et al. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J. 2004;25:1029-35.
6. Gomma AH, Hirschfield GM, Gallimore JR, Lowe GD, Pepys MB, Fox KM. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J. 2004;147:1071-7.
7. Ridker PM, Cook NR. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation. 2004;109:1955-9.
8. Heeschen C, Hamm CW, Bruemmer J, Simoons ML, for the CAPTURE Investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a Comparative analysis. J Am Coll Cardiol. 2000;35:1535-42.
9. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis. 2003;167:73-9.
10. Saleh N, Svane B, Hansson LO, Jensen J, Nilsson T, Danielsson O, et al. Response of serum C-reactive protein to percutaneous coronary interventions has prognostic value. Clin Chem. 2005;51:2124-30.
11. Hahn JY, Kim HS, Koo BK, Na SH, Chung JW, Youn TJ, et al. One-month follow-up C-reactive protein may be a useful predictor of angiographic restenosis and long-term clinical outcomes after bare metal stent implantation. Int J Cardiol. 2006;109:267-9.
12. Kinjo K, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, et al; on behalf of The Osaka Acute Coronary Insufficiency Study (OACIS) Group. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol. 2003;91:931-5.